<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17276" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Aflatoxin Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dhakal</surname>
            <given-names>Aayush</given-names>
          </name>
          <aff>OBH-Interfaith Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hashmi</surname>
            <given-names>Muhammad F.</given-names>
          </name>
          <aff>National Health Service</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sbar</surname>
            <given-names>Evelyn</given-names>
          </name>
          <aff>TTUHSC AMA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Aayush Dhakal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Hashmi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Evelyn Sbar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17276.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Aflatoxins are metabolites produced by toxigenic strains of molds, mainly Aspergillus flavus and A. parasiticus, which grow in soil, hay, decaying vegetation, and grains. Aflatoxin is produced by fungal action during food production, harvest, storage, and processing. Dietary exposure to aflatoxins may result in severe toxic and carcinogenic outcomes in humans and animals. Aflatoxin toxicity may result in nausea, vomiting, abdominal pain, convulsions, and other signs of acute liver injury. Long-term exposure also leads to various complications like growth retardation, cirrhosis, and hepatocellular carcinoma. This activity describes the evaluation and management of aflatoxin toxicity and reviews the role of the interprofessional team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the epidemiology of aflatoxin toxicity.</p></list-item><list-item><p>Outline the typical presentation of a patient with aflatoxin toxicity.</p></list-item><list-item><p>Explain the treatment options for patients with aflatoxin toxicity.</p></list-item><list-item><p>Review the importance of improving care coordination among the interprofessional team to enhance care coordination for patients affected by aflatoxin toxicity.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17276&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17276">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17276.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Aflatoxins are metabolites produced by toxigenic strains of molds, mainly&#x000a0;Aspergillus flavus&#x000a0;and&#x000a0;<italic toggle="yes">Aspergillus parasiticus</italic>, which grow in soil, hay, decaying vegetation, and grains. Aflatoxin toxicity occurs due to acute or chronic exposure to aflatoxin. The term "aflatoxin" is derived from the name Aspergillus flavus. It was named around 1960 after its discovery as the source of a disease in turkey called turkey X disease.<xref ref-type="bibr" rid="article-17276.r1">[1]</xref>&#x000a0;It was also observed as the cause of cancer in rainbow trout fed on peanut and cottonseed meals.</p>
        <p>Dietary exposure to aflatoxins may result in severe toxic and carcinogenic outcomes in humans and animals. The symptoms and biomarkers of exposure, production, and metabolism of aflatoxin and methods to reduce aflatoxin toxicity have been widely investigated over the last 50 years.<xref ref-type="bibr" rid="article-17276.r2">[2]</xref>&#x000a0;Studies have mostly focused on humans, agricultural animals, or laboratory model species and have identified species-specific aspects of aflatoxin toxicity.<xref ref-type="bibr" rid="article-17276.r3">[3]</xref><xref ref-type="bibr" rid="article-17276.r4">[4]</xref><xref ref-type="bibr" rid="article-17276.r3">[3]</xref></p>
        <p>Aflatoxins form one of the major groupings of&#x000a0;mycotoxins. Aflatoxin is produced by fungal action during the production, harvest, storage, and processing of food and feed. The US Food and Drug Administration (FDA) considers it an unavoidable contaminant of foods. Aflatoxin exposure can cause nausea, vomiting, abdominal pain, and convulsions acutely, and its chronic exposure can also lead to complications like hepatotoxicity, immunotoxicity, and teratogenicity. Aflatoxin is one of the major causes of hepatocellular carcinoma in developing countries.<xref ref-type="bibr" rid="article-17276.r5">[5]</xref></p>
        <p>Different types of aflatoxin, such as aflatoxin B1 (AFB1) and aflatoxin B2 (AFB2), are produced by both&#x000a0;<italic toggle="yes">A. flavus</italic>&#x000a0;and <italic toggle="yes">A. parasiticus</italic>.&#x000a0;AFB1 is believed to be the most potent among all aflatoxins. Aflatoxin M1 (AFM1) is found in the fermentation broth of&#x000a0;<italic toggle="yes">A. parasiticus</italic>, but it and aflatoxin M2&#x000a0;are also developed when an infected liver metabolizes AFB1 and AFB2. AFM1 can be transmitted by milk.<xref ref-type="bibr" rid="article-17276.r6">[6]</xref></p>
        <p>AFB1 and AFM1 have been classified as group 1 and group 2B human carcinogens by the International Agency for Research on Cancer (IARC).<xref ref-type="bibr" rid="article-17276.r7">[7]</xref><xref ref-type="bibr" rid="article-17276.r8">[8]</xref></p>
      </sec>
      <sec id="article-17276.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Around 25% of the world's crop is affected by mycotoxin, most of which is aflatoxin.&#x000a0;They are regularly found in improperly stored cassava, cottonseed, chili pepper, maize, wheat, millet, peanut, rice, sesame, sunflower seed, and many spices. Crops can be contaminated in two phases:</p>
        <list list-type="bullet">
          <list-item>
            <p>Aspergillus species infect crops during growth and development.</p>
          </list-item>
          <list-item>
            <p>Contamination can build during storage or transport with exposure to warm and humid conditions or severe drought.</p>
          </list-item>
        </list>
        <p>Animals fed on contaminated feed can pass aflatoxin metabolism products into eggs, milk products, and meat, and thus humans can be exposed.<xref ref-type="bibr" rid="article-17276.r8">[8]</xref></p>
        <p>Structural derivatives of difurocoumarin and aflatoxins are commonly produced by strains of&#x000a0;<italic toggle="yes">A. flavus</italic>,&#x000a0;<italic toggle="yes">A. parasiticus</italic>, and&#x000a0;<italic toggle="yes">A. minus</italic>. Furthermore,&#x000a0;many other&#x000a0;Aspergilli,&#x000a0;such as&#x000a0;Emericella&#x000a0;teleomorphs, have aflatoxigenic capabilities.&#x000a0;Named according to their green or blue color under UV light, there are&#x000a0;four primary aflatoxins. Of these, AFB&#x000a0;is the most mutagenic, the most hepatotoxic, and the most prevalent worldwide.<xref ref-type="bibr" rid="article-17276.r9">[9]</xref></p>
        <p>The following is a concise list of all the risk factors that can lead to aflatoxin exposure in humans and livestock:</p>
        <list list-type="bullet">
          <list-item>
            <p>Contaminated feed (corn, cottonseed, peanuts, sorghum, figs, tree nuts, and spices)<xref ref-type="bibr" rid="article-17276.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Stress from drought or insect damage<xref ref-type="bibr" rid="article-17276.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Warm and humid conditions</p>
          </list-item>
          <list-item>
            <p>Temperatures near 30 C (86 F)</p>
          </list-item>
          <list-item>
            <p>Substrate, CO&#x000a0;levels, time, and other environmental factors</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17276.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Around 4.5 billion people in developing countries are exposed to largely uncontrolled amounts of aflatoxin.<xref ref-type="bibr" rid="article-17276.r8">[8]</xref> Children are particularly affected by aflatoxin exposure. It is associated with growth stunting, development delays, and liver damage, ultimately leading to liver cancer. Many reports show an association between growth stunting and aflatoxin exposure in children.<xref ref-type="bibr" rid="article-17276.r12">[12]</xref><xref ref-type="bibr" rid="article-17276.r13">[13]</xref> Also, epidemiological studies are underway to establish a causal relationship between growth stunting and aflatoxin exposure. Adults have a higher tolerance for aflatoxin exposure than children, though they remain at risk. Hepatocellular carcinoma (HCC) is a well-established sequela of aflatoxin exposure, and&#x000a0;4.6% to 28.2% of all global cases of HCC can be caused by aflatoxin. Around 25% of all high-dose acute exposures may cause death.<xref ref-type="bibr" rid="article-17276.r14">[14]</xref><xref ref-type="bibr" rid="article-17276.r15">[15]</xref><xref ref-type="bibr" rid="article-17276.r16">[16]</xref></p>
      </sec>
      <sec id="article-17276.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Evidence shows that the dose and duration of aflatoxin exposure significantly affect toxicology. Exposure to large doses, known as acute aflatoxicosis, can lead to critical illness and death. High-level exposure produces acute hepatic necrosis, resulting in sequelae of cirrhosis&#x000a0;or HCC afterward. Acute liver failure manifests as fever, nausea, vomiting, abdominal pain, bleeding,&#x000a0;digestion problems, edema, malabsorption, mental changes, and coma.</p>
        <p>Exposure to chronic sublethal doses has nutritional and immunologic effects, mainly contributing to DNA alkylation by aflatoxin B1. Irrespective of the dose, all exposures have a cumulative effect on cancer risk. The carcinogenic effect of aflatoxin metabolites is via intercalation&#x000a0;into DNA and the alkylation of&#x000a0;the bases by epoxide moiety. This results in mutations in the <italic toggle="yes">p53</italic>&#x000a0;gene, an essential gene in preventing cell cycle progression in instances of DNA mutations or signaling of the programmed cell death (apoptosis).<xref ref-type="bibr" rid="article-17276.r16">[16]</xref><xref ref-type="bibr" rid="article-17276.r17">[17]</xref><xref ref-type="bibr" rid="article-17276.r18">[18]</xref></p>
        <p>Evaluating the&#x000a0;results&#x000a0;of human exposure to aflatoxin requires considering various facts. Firstly, not all ingested aflatoxin is biologically significant; a proportion of consumed aflatoxin is detoxified. The relationship between DNA-relevant exposure and carcinogenesis is understood well enough to estimate the results of changing the concentration of aflatoxins in food for the risk to humans.<xref ref-type="bibr" rid="article-17276.r19">[19]</xref>&#x000a0;Secondly, other aspects of the diet could significantly define the consequence of aflatoxin ingestion. Dietary intake of antioxidant vitamins (vitamins A, C, and E) can influence aflatoxin toxicity.<xref ref-type="bibr" rid="article-17276.r20">[20]</xref> Thirdly, the extent of biological exposure is influenced by infections, such as the hepatitis B virus and hepatitis C virus.</p>
      </sec>
      <sec id="article-17276.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The liver is the main organ affected by the toxic effects of aflatoxin. Histopathologic changes in acute hepatotoxicity due to aflatoxin toxicity are fatty changes in hepatocytes, acute hemorrhagic necrosis, and bile duct proliferation. Also, chronic aflatoxin exposure may present with histopathologic features of cirrhosis, such as nodular degeneration and fibrosis leading to distortion of the hepatic&#x000a0;architecture and HCC, which are well-vascularized tumors with wide trabeculae, small cell changes, vascular invasion, prominent acinar pattern, atypia, mitotic activity, and absence of Kupffer cells.<xref ref-type="bibr" rid="article-17276.r16">[16]</xref><xref ref-type="bibr" rid="article-17276.r21">[21]</xref><xref ref-type="bibr" rid="article-17276.r10">[10]</xref>&#x000a0;See <bold>Image.</bold>&#x000a0;Hepatocellular&#x000a0;Carcinoma.</p>
      </sec>
      <sec id="article-17276.s7" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>The most common route of entry of aflatoxin into the human body is ingestion. After entry, it is metabolized by microsomal mixed-function oxidase (MFO) enzymes in the liver to reactive epoxide&#x000a0;intermediate. MFO is an enzyme of the CYP450 superfamily. This epoxide intermediate (8,9-epoxide) is responsible for DNA mutation. The predominant mutation has been identified as the G&#x02192;T transversion in codon 249 of the p53 tumor suppressor gene. This epoxide can bind to other macromolecules like RNA and proteins, causing cellular dysregulation. It is also responsible for inhibiting proteins, RNA, and DNA synthesis. Another pathway to toxicity is glutathione depletion and subsequent toxicity from reactive oxygen species. Other pathways of carcinogenesis, catalyzed by prostaglandin H (PGH) synthase and&#x000a0;lipid peroxidase (LPO), are under study.</p>
        <p>Another pathway of aflatoxin metabolism is by microsomal biotransformation of AFB1 by hydroxylation. It leads to the formation of less toxic and non-polar metabolites like AFM1 and aflatoxin Q1 (AFQ1). Also, enzymatic and non-enzymatic action on AFB1 can produce a dialdehyde form. Aflatoxin dialdehyde is acted upon by aflatoxin aldehyde reductase (AFAR) and excreted through urine as dialcohol. It can also bind proteins, mostly albumin.<xref ref-type="bibr" rid="article-17276.r7">[7]</xref><xref ref-type="bibr" rid="article-17276.r17">[17]</xref><xref ref-type="bibr" rid="article-17276.r18">[18]</xref><xref ref-type="bibr" rid="article-17276.r22">[22]</xref></p>
      </sec>
      <sec id="article-17276.s8" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Whenever aflatoxin toxicity is suspected, a&#x000a0;thorough history regarding the patient's dietary habits, similar&#x000a0;complaints in family and community, the patient's occupation, and environmental exposure should be assessed. Health implications from aflatoxin&#x000a0;toxicity depend on&#x000a0;several factors ranging from the dose and duration of exposure to a person's gender, age, health, immunity, environmental factors, and diet. Patients with aflatoxin toxicity&#x000a0;can have a range of non-specific signs and symptoms; however, the&#x000a0;most prominent features are those of hepatotoxicity.&#x000a0;Adults generally have a good tolerance to aflatoxin, and children have higher mortality. Children tend to have severe malnutrition secondary to aflatoxin toxicity.<xref ref-type="bibr" rid="article-17276.r23">[23]</xref></p>
        <p>Acute toxicity results when someone&#x000a0;consumes&#x000a0;a high&#x000a0;level of aflatoxins in a very short time. The most common signs and symptoms are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Nausea</p>
          </list-item>
          <list-item>
            <p>Yellowing of skin and sclera (icterus)</p>
          </list-item>
          <list-item>
            <p>Itching</p>
          </list-item>
          <list-item>
            <p>Vomiting</p>
          </list-item>
          <list-item>
            <p>Bleeding</p>
          </list-item>
          <list-item>
            <p>Abdominal pain</p>
          </list-item>
          <list-item>
            <p>Lethargy</p>
          </list-item>
          <list-item>
            <p>Edema</p>
          </list-item>
          <list-item>
            <p>Convulsions</p>
          </list-item>
          <list-item>
            <p>Coma</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
        <p>Chronic&#x000a0;toxicity occurs through consuming small amounts of aflatoxins over a prolonged period. Chronic exposure to aflatoxin can result in the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Impaired growth and development, especially in children</p>
          </list-item>
          <list-item>
            <p>Immunosuppression</p>
          </list-item>
          <list-item>
            <p>Hepatocellular carcinoma (weight loss, abdominal mass, anorexia, vomiting, nausea, bleeding, psychosis, etc.)<xref ref-type="bibr" rid="article-17276.r8">[8]</xref><xref ref-type="bibr" rid="article-17276.r10">[10]</xref></p>
          </list-item>
        </list>
        <p>Maternal&#x000a0;exposure to aflatoxin&#x000a0;is associated with a higher&#x000a0;occurrence of preterm birth and late-term miscarriage.<xref ref-type="bibr" rid="article-17276.r24">[24]</xref></p>
      </sec>
      <sec id="article-17276.s9" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>An evaluation of a suspected case of aflatoxin toxicity can be done by measuring the aflatoxin level in food consumed by the patient or the aflatoxin metabolites in the patient's body.</p>
        <p>Some popular methods to detect aflatoxin exposure in food and feed are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Thin-layer chromatography (TLC)<xref ref-type="bibr" rid="article-17276.r25">[25]</xref></p>
          </list-item>
          <list-item>
            <p>High-performance liquid chromatography (HPLC)</p>
          </list-item>
          <list-item>
            <p>Liquid chromatography-mass spectroscopy (LCMS)</p>
          </list-item>
          <list-item>
            <p>Enzyme-linked immune-sorbent assay (ELISA)<xref ref-type="bibr" rid="article-17276.r26">[26]</xref></p>
          </list-item>
        </list>
        <p>ELISA using AFB1-lysine (metabolite of AFB1) concentration in the patient blood can help detect aflatoxin.</p>
        <p>Other techniques are used to detect levels of aflatoxin in the human body. One method is the measurement of the AFB-guanine adduct&#x000a0;in the urine of patients.<xref ref-type="bibr" rid="article-17276.r27">[27]</xref>&#x000a0;This technique measures only recent exposure during the past 24 hours. Due to the varying half-life of this product, its level may vary from time to time based on diet. Therefore it is not ideal for assessment of long-term exposure.&#x000a0;Measuring&#x000a0;AFB-albumin&#x000a0;adduct level in the blood serum is another method to detect aflatoxin exposure over a long period.</p>
        <p>Additionally, the assessment of liver function test include prothrombin time&#x000a0;(PT), international normalized ratio (INR), activated partial thromboplastin time&#x000a0;(aPTT), albumin, bilirubin, aspartate transaminase, and alanine transaminase. Imaging the liver using ultrasonography and CT-scan may help further study liver involvement.</p>
        <p>Other tests include the basic metabolic panel, complete blood count, and renal function, depending on patient presentation and features.<xref ref-type="bibr" rid="article-17276.r8">[8]</xref><xref ref-type="bibr" rid="article-17276.r28">[28]</xref><xref ref-type="bibr" rid="article-17276.r29">[29]</xref></p>
      </sec>
      <sec id="article-17276.s10" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Acute aflatoxicosis&#x000a0;has no known antidote, and removal of the contaminated&#x000a0;food and replacement with an uncontaminated food source may help stop further poisoning. The management is mainly focused on symptomatic and supportive care. Meeting optimum dietary requirements with the help of supplementation&#x000a0;may aid recovery. Largely, the focus of management should be on symptomatic control. Acute symptoms, such as fever, nausea, vomiting, and&#x000a0;convulsions, should be carefully addressed. If signs and symptoms suggest acute liver failure, it must be recognized early, and subsequent care should follow in a critical care setting.<xref ref-type="bibr" rid="article-17276.r30">[30]</xref><xref ref-type="bibr" rid="article-17276.r31">[31]</xref></p>
        <p>Once hepatocellular carcinoma develops, there are&#x000a0;several treatment options.<xref ref-type="bibr" rid="article-17276.r32">[32]</xref>&#x000a0;These include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Surgical resection</p>
          </list-item>
          <list-item>
            <p>Resection + ablation</p>
          </list-item>
          <list-item>
            <p>Orthotopic liver transplantation</p>
          </list-item>
          <list-item>
            <p>Thermal ablation</p>
          </list-item>
          <list-item>
            <p>Percutaneous alcohol (ethanol) injection</p>
          </list-item>
          <list-item>
            <p>Transarterial embolization</p>
          </list-item>
          <list-item>
            <p>Chemoembolization</p>
          </list-item>
          <list-item>
            <p>Radiotherapy</p>
          </list-item>
          <list-item>
            <p>Systemic chemotherapy + radioembolization</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17276.s11" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Aflatoxin toxicity is characterized by its toxic effects on the liver. So the presenting symptoms are similar to other causes of liver injury.</p>
        <p>The list of differential diagnoses of acute aflatoxicosis is as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Drug intoxication (acetaminophen, tetracycline, halothane, isoniazid, ecstasy)</p>
          </list-item>
          <list-item>
            <p>Amanita species poisoning</p>
          </list-item>
          <list-item>
            <p>Infection (hepatitis-A/B/C/D/E, cytomegalovirus, Ebstein Barr virus)</p>
          </list-item>
          <list-item>
            <p>Immunological (autoimmune hepatitis)</p>
          </list-item>
          <list-item>
            <p>Metabolic (alpha-1 antitrypsin deficiency, Wilson disease)</p>
          </list-item>
          <list-item>
            <p>Veno-occlusive diseases<xref ref-type="bibr" rid="article-17276.r30">[30]</xref><xref ref-type="bibr" rid="article-17276.r31">[31]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17276.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of aflatoxin toxicity depends upon the dosage and duration of exposure, nutritional status, immunity, and health. Acute exposure may cause nausea, vomiting, and abdominal pain, which may warrant symptomatic treatment only. Acute high-dose intoxication can be fatal in children. Chronic exposure to low-dose aflatoxin can lead to cirrhosis and hepatocellular carcinoma, which are irreversible disease conditions with high morbidity and mortality.</p>
      </sec>
      <sec id="article-17276.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Acute intoxication with a high dose of aflatoxin may result in fulminant hepatic failure and rhabdomyolysis. Chronic exposure to aflatoxin may result in liver cirrhosis and ultimately lead to hepatocellular carcinoma. Also, gall bladder carcinoma is associated with chronic toxicity.</p>
        <p>In children, aflatoxin exposure is associated with growth stunting, nutrition deficiencies, and impaired development.<xref ref-type="bibr" rid="article-17276.r16">[16]</xref><xref ref-type="bibr" rid="article-17276.r30">[30]</xref></p>
      </sec>
      <sec id="article-17276.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Aflatoxin toxicity has important impacts on agriculture, livestock, and human health. Providing knowledge to the public about aflatoxin toxicity will help to ensure food safety and decrease the incidence of aflatoxin-related health problems. Aflatoxins are found in various kinds of cereal, oilseeds, spices, nuts, and animal products. Therefore, patients should be wise in their selection of food products. In addition, farmers should keep an eye on possible aflatoxin contamination during crops' growth, harvesting, storage, and transportation.</p>
        <p>The public&#x000a0;should be informed about early signs of aflatoxin toxicity and encouraged to seek medical help without delay. Some studies have shown that a regular diet consisting of apiaceous vegetables, such as celery,&#x000a0;carrots, parsley, and parsnips,&#x000a0;may help reduce the carcinogenic&#x000a0;effects of aflatoxin.<xref ref-type="bibr" rid="article-17276.r33">[33]</xref></p>
      </sec>
      <sec id="article-17276.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management and mitigation of aflatoxin toxicity&#x000a0;encompass a wide range of professionals, such as farmers, agriculture engineers, food technicians, veterinary physicians, and other health professionals. Protecting food from aflatoxin is a significant step in limiting the health impacts of aflatoxin. Health professionals should be aware of the prevalence of aflatoxin toxicity and food practices in the region in which they live. Exposure in a patient warrants a food checkup of the patient and the family and community. This process helps trace the source of exposure and limits its effect.</p>
        <p>The majority of presenting cases of aflatoxin toxicity are late presentations after chronic exposures. Aflatoxin toxicity is one of the major causes of liver cirrhosis and hepatocellular carcinoma in developing countries. Acute high-dose exposures are rare, and most severe cases occur in children. Recognition of this condition throughout multiple contact points in the healthcare system is imperative. An interprofessional healthcare team is critical to successfully identifying and managing these toxicities. High-dose acute intoxication may require admission and close monitoring as life-threatening fulminant hepatitis will need intensive care support.<xref ref-type="bibr" rid="article-17276.r8">[8]</xref><xref ref-type="bibr" rid="article-17276.r16">[16]</xref>&#x000a0;[Level 5]</p>
      </sec>
      <sec id="article-17276.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17276&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17276">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/wilderness-and-environmental/aflatoxin-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17276">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17276/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17276">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17276.s17">
        <fig id="article-17276.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Hepatocellular Carcinoma Contributed by S Rafay Zaidi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HCC-Edited" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17276.s18">
        <title>References</title>
        <ref id="article-17276.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de IONGH</surname>
              </name>
              <name>
                <surname>BEERTHUIS</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>VLES</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>BARRETT</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>ORD</surname>
                <given-names>WO</given-names>
              </name>
            </person-group>
            <article-title>Investigation of the factor in groundnut meal responsible for "turkey X disease".</article-title>
            <source>Biochim Biophys Acta</source>
            <year>1962</year>
            <month>Dec</month>
            <day>17</day>
            <volume>65</volume>
            <fpage>548</fpage>
            <page-range>548-51</page-range>
            <pub-id pub-id-type="pmid">13956640</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wogan</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Kensler</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Groopman</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.</article-title>
            <source>Food Addit Contam Part A Chem Anal Control Expo Risk Assess</source>
            <year>2012</year>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>249</fpage>
            <page-range>249-57</page-range>
            <pub-id pub-id-type="pmid">21623489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magnussen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parsi</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Aflatoxins, hepatocellular carcinoma and public health.</article-title>
            <source>World J Gastroenterol</source>
            <year>2013</year>
            <month>Mar</month>
            <day>14</day>
            <volume>19</volume>
            <issue>10</issue>
            <fpage>1508</fpage>
            <page-range>1508-12</page-range>
            <pub-id pub-id-type="pmid">23539499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>YX</given-names>
              </name>
              <name>
                <surname>Qu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jiao</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.</article-title>
            <source>Gastroenterology</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>153</volume>
            <issue>1</issue>
            <fpage>249</fpage>
            <page-range>249-262.e2</page-range>
            <pub-id pub-id-type="pmid">28363643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kew</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment.</article-title>
            <source>World J Hepatol</source>
            <year>2012</year>
            <month>Mar</month>
            <day>27</day>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>99</fpage>
            <page-range>99-104</page-range>
            <pub-id pub-id-type="pmid">22489262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamkar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yazdankhah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nafchi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Nejad</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Aflatoxin M1 in raw cow and buffalo milk in Shush city of Iran.</article-title>
            <source>Food Addit Contam Part B Surveill</source>
            <year>2014</year>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-4</page-range>
            <pub-id pub-id-type="pmid">24779974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marchese</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Polo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ariano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Velotto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Costantini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Severino</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Aflatoxin B1 and M1: Biological Properties and Their Involvement in Cancer Development.</article-title>
            <source>Toxins (Basel)</source>
            <year>2018</year>
            <month>May</month>
            <day>24</day>
            <volume>10</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">29794965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mahato</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Kamle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mohanta</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Aflatoxins: A Global Concern for Food Safety, Human Health and Their Management.</article-title>
            <source>Front Microbiol</source>
            <year>2016</year>
            <volume>7</volume>
            <fpage>2170</fpage>
            <pub-id pub-id-type="pmid">28144235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rawal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Coulombe</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Aflatoxin B1 in poultry: toxicology, metabolism and prevention.</article-title>
            <source>Res Vet Sci</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>89</volume>
            <issue>3</issue>
            <fpage>325</fpage>
            <page-range>325-31</page-range>
            <pub-id pub-id-type="pmid">20462619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarma</surname>
                <given-names>UP</given-names>
              </name>
              <name>
                <surname>Bhetaria</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Devi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Varma</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Aflatoxins: Implications on Health.</article-title>
            <source>Indian J Clin Biochem</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>124</fpage>
            <page-range>124-133</page-range>
            <pub-id pub-id-type="pmid">28428686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kebede</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Abbas</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Bellaloui</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Relationship between aflatoxin contamination and physiological responses of corn plants under drought and heat stress.</article-title>
            <source>Toxins (Basel)</source>
            <year>2012</year>
            <month>Nov</month>
            <day>20</day>
            <volume>4</volume>
            <issue>11</issue>
            <fpage>1385</fpage>
            <page-range>1385-403</page-range>
            <pub-id pub-id-type="pmid">23202322</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khlangwiset</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shephard</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Aflatoxins and growth impairment: a review.</article-title>
            <source>Crit Rev Toxicol</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>41</volume>
            <issue>9</issue>
            <fpage>740</fpage>
            <page-range>740-55</page-range>
            <pub-id pub-id-type="pmid">21711088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Voth-Gaeddert</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Stoker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Oerther</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Association of aflatoxin exposure and height-for-age among young children in Guatemala.</article-title>
            <source>Int J Environ Health Res</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>280</fpage>
            <page-range>280-292</page-range>
            <pub-id pub-id-type="pmid">29706087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boonen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Malysheva</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Taevernier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Diana Di Mavungu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>De Saeger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Spiegeleer</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Human skin penetration of selected model mycotoxins.</article-title>
            <source>Toxicology</source>
            <year>2012</year>
            <month>Nov</month>
            <day>15</day>
            <volume>301</volume>
            <issue>1-3</issue>
            <fpage>21</fpage>
            <page-range>21-32</page-range>
            <pub-id pub-id-type="pmid">22749975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.</article-title>
            <source>Environ Health Perspect</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>118</volume>
            <issue>6</issue>
            <fpage>818</fpage>
            <page-range>818-24</page-range>
            <pub-id pub-id-type="pmid">20172840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Jolly</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Stiles</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Jolly</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>80</volume>
            <issue>5</issue>
            <fpage>1106</fpage>
            <page-range>1106-22</page-range>
            <pub-id pub-id-type="pmid">15531656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aguilar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Cerutti</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Aflatoxin B1 induces the transversion of G--&#x0003e;T in codon 249 of the p53 tumor suppressor gene in human hepatocytes.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1993</year>
            <month>Sep</month>
            <day>15</day>
            <volume>90</volume>
            <issue>18</issue>
            <fpage>8586</fpage>
            <page-range>8586-90</page-range>
            <pub-id pub-id-type="pmid">8397412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jolly</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Inusah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>WO</given-names>
              </name>
              <name>
                <surname>Nyarko</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Association between high aflatoxin B<sub>1</sub> levels and high viral load in HIV-positive people.</article-title>
            <source>World Mycotoxin J</source>
            <year>2013</year>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>255</fpage>
            <page-range>255-261</page-range>
            <pub-id pub-id-type="pmid">31534557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henry</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Bosch</surname>
                <given-names>FX</given-names>
              </name>
              <name>
                <surname>Troxell</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Bolger</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Policy forum: public health. Reducing liver cancer--global control of aflatoxin.</article-title>
            <source>Science</source>
            <year>1999</year>
            <month>Dec</month>
            <day>24</day>
            <volume>286</volume>
            <issue>5449</issue>
            <fpage>2453</fpage>
            <page-range>2453-4</page-range>
            <pub-id pub-id-type="pmid">10636808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Shukla</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>DN</given-names>
              </name>
            </person-group>
            <article-title>Amelioration of cytotoxic effects of aflatoxin by vitamin A: an in vitro study on erythrocytes.</article-title>
            <source>Toxicol In Vitro</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-42</page-range>
            <pub-id pub-id-type="pmid">11259868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colakoglu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Donmez</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Effects of aflatoxin on liver and protective effectiveness of esterified glucomannan in Merino rams.</article-title>
            <source>ScientificWorldJournal</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>462925</fpage>
            <pub-id pub-id-type="pmid">23304087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallagher</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Kunze</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Stapleton</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Eaton</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>141</volume>
            <issue>2</issue>
            <fpage>595</fpage>
            <page-range>595-606</page-range>
            <pub-id pub-id-type="pmid">8975785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McMillan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Renaud</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Burgess</surname>
                <given-names>KMN</given-names>
              </name>
              <name>
                <surname>Orimadegun</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Akinyinka</surname>
                <given-names>OO</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sumarah</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Aflatoxin exposure in Nigerian children with severe acute malnutrition.</article-title>
            <source>Food Chem Toxicol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>111</volume>
            <fpage>356</fpage>
            <page-range>356-362</page-range>
            <pub-id pub-id-type="pmid">29175577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kyei</surname>
                <given-names>NNA</given-names>
              </name>
              <name>
                <surname>Boakye</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gabrysch</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Maternal mycotoxin exposure and adverse pregnancy outcomes: a systematic review.</article-title>
            <source>Mycotoxin Res</source>
            <year>2020</year>
            <month>May</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>243</fpage>
            <page-range>243-255</page-range>
            <pub-id pub-id-type="pmid">31989413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kotinagu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mohanamba</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kumari</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Assessment of aflatoxin B1 in livestock feed and feed ingredients by high-performance thin layer chromatography.</article-title>
            <source>Vet World</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>12</issue>
            <fpage>1396</fpage>
            <page-range>1396-9</page-range>
            <pub-id pub-id-type="pmid">27047050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beyene</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>E Schrunk</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ensley</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rumbeiha</surname>
                <given-names>WK</given-names>
              </name>
            </person-group>
            <article-title>High-performance liquid chromatography and Enzyme-Linked Immunosorbent Assay techniques for detection and quantification of aflatoxin B<sub>1</sub> in feed samples: a comparative study.</article-title>
            <source>BMC Res Notes</source>
            <year>2019</year>
            <month>Aug</month>
            <day>07</day>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>492</fpage>
            <pub-id pub-id-type="pmid">31391088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Groopman</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Cain</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Kensler</surname>
                <given-names>TW</given-names>
              </name>
            </person-group>
            <article-title>Aflatoxin exposure in human populations: measurements and relationship to cancer.</article-title>
            <source>Crit Rev Toxicol</source>
            <year>1988</year>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-45</page-range>
            <pub-id pub-id-type="pmid">3069332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kensler</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Roebuck</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Wogan</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Groopman</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology.</article-title>
            <source>Toxicol Sci</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>120 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>S28</fpage>
            <page-range>S28-48</page-range>
            <pub-id pub-id-type="pmid">20881231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Makarananda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pengpan</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Srisakulthong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yoovathaworn</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sriwatanakul</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Monitoring of aflatoxin exposure by biomarkers.</article-title>
            <source>J Toxicol Sci</source>
            <year>1998</year>
            <month>Jul</month>
            <volume>23 Suppl 2</volume>
            <fpage>155</fpage>
            <page-range>155-9</page-range>
            <pub-id pub-id-type="pmid">9760454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Samuel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ezri</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Farah</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Igor</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hussein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rubinshtein</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Assy</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Acute Aflatoxicosis Resulting in Fulminant Hepatic Failure and Rhabdomyolysis.</article-title>
            <source>Gastroenterology Res</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-50</page-range>
            <pub-id pub-id-type="pmid">27956951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Panackel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sebastian</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mathai</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Recent advances in management of acute liver failure.</article-title>
            <source>Indian J Crit Care Med</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-33</page-range>
            <pub-id pub-id-type="pmid">25624647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dimitroulis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Damaskos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Valsami</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Davakis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garmpis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Spartalis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Athanasiou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moris</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sakellariou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kykalos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsourouflis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Garmpi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Delladetsima</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kontzoglou</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kouraklis</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.</article-title>
            <source>World J Gastroenterol</source>
            <year>2017</year>
            <month>Aug</month>
            <day>07</day>
            <volume>23</volume>
            <issue>29</issue>
            <fpage>5282</fpage>
            <page-range>5282-5294</page-range>
            <pub-id pub-id-type="pmid">28839428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17276.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peterson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lampe</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Bammler</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Gross-Steinmeyer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Eaton</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1.</article-title>
            <source>Food Chem Toxicol</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>44</volume>
            <issue>9</issue>
            <fpage>1474</fpage>
            <page-range>1474-84</page-range>
            <pub-id pub-id-type="pmid">16762476</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
